# Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

> **NCT04080635** · NA · RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 100 (estimated)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **PROCEDURE:** Venapuncture
- **OTHER:** Patient questionnaires

## Key facts

- **NCT ID:** NCT04080635
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-14
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080635, "Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04080635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*